Govt sets up committee for coronavirus vaccine distribution

Govt sets up committee for coronavirus vaccine distribution

"And to ensure maximum immunization coverage and contain the pandemic, it is important to make sure that the most remote and poorest countries of the world have access to affordable cure and preventive measures", said institute CEO Adar Poonawalla.

As part of the deal, Serum Institute has set a price ceiling of $3 (around Rs 225) per dose, made available to up to 92 countries included those under Gavi's COVAX Advance Market Commitment (AMC).

The company which is the largest vaccine manufacturer of the world has already signed deals with two of the leading Covid-19 vaccine candidates-Oxford University-AstraZeneca and Novavax- to develop, manufacture and sell the vaccine in India along with some other developing nations.

Indian Drug controller has also permitted SII to undertake phase 2 and 3 human trials on Covishield in India.


The agreement between the organizations is aimed at fast-tracking the mass-production of candidate vaccines developed by UK's Oxford University-AstraZeneca and America's Novavax.

It is to be noted that SII's vaccine productions for the 2 candidates shall be procured only if they successful get a "thumbs up", or manages to get the full licensing from WHO. It will have the exclusive rights for the vaccine in India (during the term of the deal) and non-exclusive rights during the "pandemic period" in all countries apart from upper-middle or high income countries.

The shot from AstraZeneca is already in the final stage, while Novavax's candidate is expected to go into Phase-3 next month. In the past, SII has had a long history of partnering with GAVI and other pharmaceutical companies for producing to fight meningitis, diarrhoea, pneumonia and measles.

Speaking about the move, Dr Balram Bhargava, Director General of Indian Council of Medical Research (ICMR), commented, "India's has demonstrated consistent capability in delivering on low-priced and high-quality medical research, while also maintaining technical and scientific rigour". The panel which will be led by Niti Aayog's Dr VK Paul and co-chaired by health secretary Rajesh Bhushan includes AIIMS director Dr Randeep Guleria, representatives of the ministries of external affairs, biotechnology, information technology, the Director General of Health services, India's Aids Research Institute, the Indian Council of Medical Research, and also representatives from states.

Related:

Comments

Latest news

U.S. intelligence says Russia, China and Iran will attempt election interference
Despite those efforts, officials see it as unlikely that anyone could manipulate voting results in any sweeping way, Evanina said. Mr Trump expressed faith in this finding by officials, stating that: "If Joe Biden was president, China would own our country".

Biden Risks Alienating Young Black Voters After Race Remarks
Tammy Duckworth are reportedly legitimate candidates, as well, according to reports. "We're going to have a Black woman VP". Close to a dozen women have been thought to be candidates for Biden's running mate this summer.

Seven die in fire at Covid-19 hotel facility in India
The Prime Minister extended all the possible help and assured support to the families of the victims. A fire accident has happened in Hotel Swarna Palace which was turned into a COVID Care Center.

Mauritius Declares An Environmental Emergency After Tanker Spills Tons Of Oil
Nagashiki Shipping Company said it had tried to free the tanker but the effort was hampered by persistent bad weather. Video posted online showed oily water lapping at the shore as people murmured and peered at the ship in the distance.

Cardi B And Megan Thee Stallion Drop Their New Tune "WAP"
She added that there will be "several" more female rappers finding fame through social media platforms. One user said that the person who chose to give Kylie more time than Mulatto will be dealt with.

Other news